3759.HK
PHARMARON
HK$17.52
+0.75%
2026-05-29
About PHARMARON
Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally. It operates through five segments: Laboratory Services; Chemical and Formulation Process Development and Manufacturing Services; Clinical Research Services; Macromolecule and Cell and Gene Therapy Services; and Others. The company offers laboratory chemistry and biological science services, including small molecule chemical drugs, oligonucleotides, peptides, antibodies, antimicrobial agents, antibody-drug conjugates (ADCs), and cell and gene therapy products; small molecule CDMO services, such as API process development and production, material science and preformulation, formulation development, and analytical development. It also provides clinical research services; macromolecular and cell and gene therapy services comprising drug discovery, development and production services, cell and gene therapy laboratory services, and gene therapy drug development and production services. In addition, the company is involved in the provision of technology development, technology transfer, technical consultation, technical services, and technical training; import and export of goods and technologies. Pharmaron Beijing Co., Ltd. was incorporated in 2004 and is headquartered in Beijing, the People's Republic of China.
Key Fundamentals
P/E Ratio
17.74
Forward P/E
12.12
EPS (TTM)
HK$1.09
ROE
10.0%
Revenue Growth (YoY)
15.5%
Profit Margin
11.6%
Debt/Equity
41.49
Dividend Yield
1.1%
Price/Book
1.87
Beta
0.83
Market Cap
HK$35.53B
Avg Volume (10D)
7.2M
Recent Breakout Signals
No recent breakout signals detected for 3759.HK.
Recent Price Range (60 Days)
60D High
HK$22.32
60D Low
HK$17.11
Avg Volume
6.0M
Latest Close
HK$17.52
Get breakout alerts for 3759.HK
Sign up for Breakout Scanner to receive daily notifications when 3759.HK triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
PHARMARON (3759.HK) is listed on the Hong Kong Exchanges (HKEX). Breakout Scanner monitors 3759.HK daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. 3759.HK operates in the Healthcare sector within the Biotechnology industry. Data is provided for informational purposes only and does not constitute financial advice.